A company that says it is developing a potential COVID-19 vaccine has asked for court action that would require a DNA manufacturing firm to divulge proprietary techniques in the hopes of ramping up production of a drug that could end the pandemic, but a Pennsylvania trial court judge has denied that request.

Judge Jeffrey Saltz of the Montgomery County Court of Common Pleas on Thursday denied a request for injunction that Plymouth Meeting-based drugmaker Inovio sought that would have compelled South Korean DNA manufacturer VGXI to transfer proprietary manufacturing processes to as many as 10 other manufacturers.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]